Agustín B.
- Country
- Spain
- Department
- Lipids Unit
Research Overview
- Effect of Muvalaplin on Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: A Phase 3 Randomized Trial
- Evaluation of ISIS 678354 Sodium Salt in Patients with Severe Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial
- Phase 3 Double-Blind, Placebo-Controlled Trial Evaluating Plozasiran Efficacy and Safety in Adults with Severe Hypertriglyceridemia
Data & Insights
Has run more than one trial at 126 of 461 partner sites.
Specializations
Cardiovascular Prevention
This investigator specializes in primary prevention of atherosclerotic cardiovascular disease (ASCVD), focusing on innovative therapeutic approaches for patients at high cardiovascular risk.
- Cardiovascular event prevention
- Risk reduction strategies
- Atherosclerosis management
The research encompasses evaluation of novel treatments for reducing major adverse cardiovascular events in high-risk populations.
Lipid Disorders
The investigator has particular expertise in treating severe hypertriglyceridemia (SHTG) and familial chylomicronemia syndrome (FCS), exploring advanced therapeutic options for these conditions.
- Triglyceride reduction therapies
- Rare lipid disorders
- Metabolic disease management
Their work involves evaluating novel approaches for managing severe lipid disorders and associated metabolic conditions.
Pediatric Lipidology
The investigator conducts research in pediatric lipid disorders, particularly heterozygous familial hypercholesterolemia (HeFH) in children and adolescents aged 6 to 17 years.
- Pediatric lipid management
- Genetic cholesterol disorders
- Early intervention strategies
Their research focuses on developing age-appropriate treatments for inherited lipid disorders in young patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.